X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs DIVIS LABORATORIES - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH DIVIS LABORATORIES STERLING BIOTECH/
DIVIS LABORATORIES
 
P/E (TTM) x -1.8 18.7 - View Chart
P/BV x 0.1 4.1 1.7% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 STERLING BIOTECH   DIVIS LABORATORIES
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
DIVIS LABORATORIES
Mar-16
STERLING BIOTECH/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs112,484 0.4%   
Low Rs3918 0.4%   
Sales per share (Unadj.) Rs26.8142.3 18.8%  
Earnings per share (Unadj.) Rs-15.041.9 -35.7%  
Cash flow per share (Unadj.) Rs-5.546.3 -11.8%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs54.9161.5 34.0%  
Shares outstanding (eoy) m267.87265.47 100.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.312.0 2.2%   
Avg P/E ratio x-0.540.6 -1.1%  
P/CF ratio (eoy) x-1.336.7 -3.5%  
Price / Book Value ratio x0.110.5 1.2%  
Dividend payout %023.9 0.0%   
Avg Mkt Cap Rs m1,862451,525 0.4%   
No. of employees `0001.43.7 36.5%   
Total wages/salary Rs m5473,649 15.0%   
Avg. sales/employee Rs Th5,303.310,184.4 52.1%   
Avg. wages/employee Rs Th403.8984.1 41.0%   
Avg. net profit/employee Rs Th-2,959.02,998.5 -98.7%   
INCOME DATA
Net Sales Rs m7,18137,764 19.0%  
Other income Rs m43848 5.0%   
Total revenues Rs m7,22338,612 18.7%   
Gross profit Rs m94714,138 6.7%  
Depreciation Rs m2,5431,182 215.2%   
Interest Rs m4,37723 18,866.8%   
Profit before tax Rs m-5,93113,781 -43.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9242,662 -72.3%   
Profit after tax Rs m-4,00711,119 -36.0%  
Gross profit margin %13.237.4 35.2%  
Effective tax rate %32.419.3 167.9%   
Net profit margin %-55.829.4 -189.5%  
BALANCE SHEET DATA
Current assets Rs m14,33530,947 46.3%   
Current liabilities Rs m49,8095,195 958.8%   
Net working cap to sales %-494.068.2 -724.5%  
Current ratio x0.36.0 4.8%  
Inventory Days Days403117 345.5%  
Debtors Days Days17185 200.4%  
Net fixed assets Rs m55,43217,027 325.6%   
Share capital Rs m268531 50.5%   
"Free" reserves Rs m13,93542,341 32.9%   
Net worth Rs m14,70142,877 34.3%   
Long term debt Rs m9,4785 201,656.4%   
Total assets Rs m73,98849,684 148.9%  
Interest coverage x-0.4595.0 -0.1%   
Debt to equity ratio x0.60 588,142.3%  
Sales to assets ratio x0.10.8 12.8%   
Return on assets %0.522.4 2.2%  
Return on equity %-27.325.9 -105.1%  
Return on capital %-6.432.2 -20.0%  
Exports to sales %25.985.3 30.4%   
Imports to sales %0.222.9 0.7%   
Exports (fob) Rs m1,86032,198 5.8%   
Imports (cif) Rs m128,654 0.1%   
Fx inflow Rs m1,86032,270 5.8%   
Fx outflow Rs m258,775 0.3%   
Net fx Rs m1,83523,496 7.8%   
CASH FLOW
From Operations Rs m1,71910,379 16.6%  
From Investments Rs m-3,148-4,135 76.1%  
From Financial Activity Rs m1,426-6,241 -22.8%  
Net Cashflow Rs m-33 -103.0%  

Share Holding

Indian Promoters % 33.9 52.0 65.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.8 -  
FIIs % 9.9 19.0 52.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 17.2 228.5%  
Shareholders   21,482 31,796 67.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 24, 2017 11:11 AM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS